{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for dexamethasone root_modifications_agentModifications_agentSubstance_refPname in root_modifications_agentModifications_agentSubstance_refPname (approximate match)
Showing 1 - 7 of 7 results
Status:
Investigational
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
INN:tesrivetcel [INN]
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT03694405: Phase 4 Interventional Completed Meningococcal Disease, Invasive
(2018)
Source URL:
First approved in 2010
Source:
BLA125300
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT03694405: Phase 4 Interventional Completed Meningococcal Disease, Invasive
(2018)
Source URL:
First approved in 2010
Source:
BLA125300
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT03694405: Phase 4 Interventional Completed Meningococcal Disease, Invasive
(2018)
Source URL:
First approved in 2010
Source:
BLA125300
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT03694405: Phase 4 Interventional Completed Meningococcal Disease, Invasive
(2018)
Source URL:
First approved in 2010
Source:
BLA125300
Source URL:
Class:
STRUCTURALLY DIVERSE